Clinical Trials Logo

Filter by:
NCT ID: NCT02508389 Completed - Clinical trials for Radiation Induced Oral Mucositis

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Start date: October 12, 2015
Phase: Phase 2
Study type: Interventional

The purpose of the phase 2, GT-201 clinical study is to determine if GC4419 administered prior to intensity-modulated radiation therapy (IMRT) reduces the incidence, duration, and severity of radiation induced oral mucositis in patients who have been diagnosed with locally advanced, non-metastatic squamous cell carcinoma of the head and neck.

NCT ID: NCT02507999 Completed - Cerebral Aneurysm Clinical Trials

Goal-directed Therapy in Endovascular Coiling of Cerebral Aneurysm Patients

Start date: November 2015
Phase: N/A
Study type: Interventional

Goal directed therapy (GDT) is a technique, which employs a non-invasive cardiac output monitoring (NICOM) device to guide management of circulating blood volume and blood pressure during procedures. The purpose of this study is to determine whether the use of goal-directed therapy to optimize blood volume and cardiac output during the procedure can improve the outcome of patients undergoing endovascular treatment of a brain aneurysm.

NCT ID: NCT02507687 Completed - Ocular Hypertension Clinical Trials

Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

Start date: August 27, 2015
Phase: Phase 3
Study type: Interventional

This study will evaluate the intraocular pressure (IOP)-lowering effect and safety of bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy (e.g., due to intolerance or nonadherence).

NCT ID: NCT02507505 Completed - Hip Fractures Clinical Trials

Regional Versus General Anesthesia for Promoting Independence After Hip Fracture

REGAIN
Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if two types of standard care anesthesia are the same or if one is better for people who have hip fractures.

NCT ID: NCT02506972 Completed - Diabetes Mellitus Clinical Trials

Effect of Serving Size and Addition of Sugar on the Glycemic Response Elicited by Oatmeal

Panther
Start date: November 2013
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the impact of serving size and the addition of sugar on the glycemic response elicited by oatmeal compared to that elicited by cream of rice cereal.

NCT ID: NCT02506517 Completed - Solid Tumors Clinical Trials

A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene

Start date: August 2015
Phase: Phase 2
Study type: Interventional

This is a phase 2 study (the second phase in testing a new drug) to see how useful an investigational drug called afatinib is in patients with advanced cancer with changes in the HER gene. Afatinib is a drug that is approved by Health Canada for the treatment of advanced lung cancer with changes in the HER gene. Afatinib works by attaching to and blocking a protein called HER from working. HER is an important protein that contributes to the growth of cancer cells.

NCT ID: NCT02506465 Completed - Clinical trials for Benign Prostate Hyperplasia

Pivotal Study to Assess the Safety and Effectiveness of the iTind Device

Start date: July 2015
Phase: N/A
Study type: Interventional

The study objectives are to demonstrate the efficacy and safety of the Medi-Tate iTIND as compared to control group (catheter only).

NCT ID: NCT02506179 Completed - Ulcerative Colitis Clinical Trials

Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

UCanADA
Start date: August 18, 2015
Phase:
Study type: Observational

To evaluate the real-life effect after 1 year of adalimumab treatment on psychological distress/depression symptoms in moderate-to-severe Ulcerative Colitis (UC) patients.

NCT ID: NCT02506062 Completed - Raynaud Disease Clinical Trials

A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)

Start date: July 2015
Phase: N/A
Study type: Interventional

This trial will test the efficacy of brief periods of controlled limb ischemia (remote ischemic preconditioning, RIPC) as an effective treatment of patients with Raynaud's Phenomenon (RP).The hypothesis of this trial is that due to its vasoprotective effects, RIPC would be more effective than placebo in the treatment of both primary and secondary RP, as defined by decreased frequency, duration, and severity of attacks. This trial was also designed to monitor the tolerance of RIPC in a rheumatologic population. Patients will not be required to stop any current treatment for RP.

NCT ID: NCT02505971 Completed - Clinical trials for Infantile Hemangioma

Nadolol Versus Propranolol in Children With Infantile Hemangiomas

Start date: September 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of oral propranolol versus nadolol in patients with Infantile Hemangiomas (IH) in a randomized, controlled, double-blinded study.